###begin article-title 0
###xml 17 23 17 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 28 34 28 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A4</italic>
Polymorphisms in COL4A3 and COL4A4 genes associated with keratoconus
###end article-title 0
###begin p 1
The first two authors contributed equally to this work
###end p 1
###begin title 2
Purpose
###end title 2
###begin p 3
###xml 42 48 42 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 81 87 81 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A4</italic>
###xml 251 257 251 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 262 268 262 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A4</italic>
###xml 281 289 <span type="species:ncbi:9606">patients</span>
###xml 375 383 <span type="species:ncbi:9606">patients</span>
Alterations in collagen type IV, alpha-3 (COL4A3) and collagen type IV, alpha-4 (COL4A4) genes may be responsible for a decrease in collagen types I and III, a feature often detected in keratoconus (KC). To evaluate the significance of alterations in COL4A3 and COL4A4 genes in KC patients, we screened both genes and estimated the significance of polymorphisms in Slovenian patients with KC.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 335 341 335 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 346 352 346 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A4</italic>
###xml 33 41 <span type="species:ncbi:9606">patients</span>
###xml 554 562 <span type="species:ncbi:9606">patients</span>
The study included 104 unrelated patients with KC and 157 healthy blood donors. Diagnosis was established by clinical examination, electronic refractometry, and keratometry. DNA was extracted from blood, and gene exons were amplified by PCR. Non-isotopic high-resolution single-stranded conformation analysis (SSCA) was used to screen COL4A3 and COL4A4 genes, and migration shifts detected by SSCA were subsequently sequenced. For statistical evaluation, control blood donors were chosen according to age, sex, and not having blood relationship. Neither patients nor control blood donors chosen for statistical analysis were in blood relationship. We used Fisher's exact test for statistical evaluation, with p<0.05 considered significant.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 39 45 39 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 66 72 66 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A4</italic>
###xml 110 116 110 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 142 148 142 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A4</italic>
###xml 363 369 363 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 411 417 411 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A4</italic>
###xml 185 193 <span type="species:ncbi:9606">patients</span>
###xml 483 491 <span type="species:ncbi:9606">patients</span>
We detected eight polymorphisms in the COL4A3 gene and six in the COL4A4 gene. Allele differences in D326Y in COL4A3 and M1237V and F1644F in COL4A4 are significantly distinctive of KC patients (Fisher's exact test, p<0.05). When analyzing different genotypes under three models (dominant, recessive, and additive), we established that P141L, D326Y, and G895G in COL4A3 and P482S, M1327V, V1516V, and F1644F in COL4A4 have significant differences in genotype distribution between KC patients and the control group.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 42 48 42 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 53 59 53 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A4</italic>
###xml 174 180 174 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 185 191 185 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A4</italic>
###xml 72 80 <span type="species:ncbi:9606">patients</span>
###xml 228 236 <span type="species:ncbi:9606">patients</span>
This is the first mutational screening of COL4A3 and COL4A4 genes in KC patients to establish the status of these genes and compare them to a control population. Analysis of COL4A3 and COL4A4 revealed no mutations related to KC patients, but specific genotypes of seven previously described polymorphisms are significantly associated with KC under dominant, recessive, or additive models. Differences in the expression of type IV collagen in previously published data about chromosomal instabilities in the regions in which the analyzed genes were mapped and our data indicate a probability that some of the polymorphisms we detected could be related to KC.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 148 149 148 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 244 245 244 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 675 676 675 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 677 678 677 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 734 735 734 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 736 737 736 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 910 911 910 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 912 913 912 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 1111 1112 1111 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 1662 1663 1662 1663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 1664 1665 1664 1665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
Keratoconus (KC) is a noninflammatory progressive thinning disorder of the cornea that leads to progressive mixed myopic and irregular astigmatism [1]. The estimated incidence of KC is between 1 in 500 and 1 in 2,000 in the general population [1]. KC occurs in all ethnic groups, with no significant gender difference. The age of onset is puberty, and KC is progressive until the third to fourth decade of life when it usually arrests. It is the major cause of cornea transplantation in developed countries. Although the cause of KC is unknown, there are several lines of evidence suggesting a genetic component. These include a positive family history in 6-10% of KC cases [1,2] and its higher concordance rate in monozygotic twins [1,3]. Although the disease has been reported to exhibit familiar patterns and an autosomal recessive mode of inheritance has been postulated, most cases appear to be sporadic [4,5] Hereditary KC is inherited dominantly or recessively, but families are frequently diagnosed with autosomal dominant, which presents incomplete penetrance of the disease and variable expressivity [5]. The underlying biochemical processes and their cause remain poorly understood. By far the most common presentation of KC is as an isolated sporadic disorder, but a positive association between KC and many conditions has been suggested, including atopy, eye rubbing, wearing hard contact lens, and cardiovascular disease (especially mitral valve prolapse) as well as some rare genetic disorders, connective tissue disorders, pigmentary retinopathy, Marfan's syndrome, Noonan's syndrome, Apert's syndrome, Ehlers-Danlos syndrome, and Down syndrome [1,6].
###end p 11
###begin p 12
###xml 139 140 139 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 226 227 226 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 355 356 355 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 523 525 523 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 526 528 526 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 610 616 606 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL8A1</italic>
###xml 637 643 629 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL8A2</italic>
###xml 749 751 741 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 825 827 817 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 858 864 850 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL8A2</italic>
###xml 938 940 930 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 941 943 933 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 1350 1352 1342 1344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 1353 1355 1345 1347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 1473 1475 1465 1467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 1496 1498 1488 1490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 1768 1770 1760 1762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 1771 1773 1763 1765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 156 164 <span type="species:ncbi:9606">patients</span>
###xml 542 547 <span type="species:ncbi:10090">mouse</span>
The major protein in the cornea is collagen, and several types of collagen have been identified by biochemical and immunochemical methods [7]. Corneas from patients with KC contain reduced amounts of total collagen proteins, [8] and alterations of the extra cellular matrix and basement membrane are characterized mostly by a decrease in types I and III [9]. The changes in the orientation of collagen molecules, which are followed by rearrangement of collagen fibrils, also alter the shape and transparency of the cornea [10,11]. A knockout mouse model has shown that disruption of the genes encoding alpha1 (COL8A1) and alpha2 chains (COL8A2) of type VIII collagen leads to structural changes similar to the clinical presentation of keratoglobus [12]. KC has not been associated with mutations in type VIII collagen genes [13], although a relation between COL8A2 mutations and dystrophic corneal disorders has previously been reported [14,15]. Results from imunohistochemistry, in situ hybridization, and expression arrays show that several other types of collagen are differentially expressed and have an active role in wound healing processes. Collagen molecules that are differentially expressed in keratoconus corneas are types XII, XIII, XVIII, and XV, but there are no known relations between mutations and expression levels for those genes [16,17]. Upregulation of collagen type XV and downregulation of collagen type IV in KC corneas, observed by Bochert et al. [18] and Stachs et al. [19], showed the putative role of those types of collagen in KC. Types XIII, XV, and XVIII collagen were found to be expressed in basal corneal cells and may have a role in the adhesion of the corneal epithelial cells to each other and to the underlying basement membrane [16,19].
###end p 12
###begin p 13
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 156 162 156 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 195 201 195 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A4</italic>
###xml 303 305 303 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 312 318 312 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 367 373 367 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A4</italic>
###xml 435 437 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 438 440 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 443 449 443 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 454 460 454 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A4</italic>
###xml 542 544 538 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 545 547 541 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 548 550 544 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 753 755 749 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 756 758 752 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 759 761 755 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 764 770 760 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 856 858 852 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 859 861 855 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 947 949 943 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 950 952 946 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 1080 1082 1076 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 1264 1270 1252 1258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 1275 1281 1263 1269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A4</italic>
###xml 1296 1304 <span type="species:ncbi:9606">patients</span>
Type IV collagen is found only in basement membranes where it is the major structural component. Mariyama et al. [20] mapped the collagen type IV, alpha-3 (COL4A3) and collagen type IV, alpha-4 (COL4A4) genes to the same region, 2q35-q37, but on opposite strands and transcribed in opposite directions [21]. The COL4A3 gene spans 250 kb and consists of 51 exons; the COL4A4 gene is shorter, spanning 113 kb and consisting of 48 exons [20,22]. COL4A3 and COL4A4 are two of six alpha chains that form heterotrimeric type IV collagen molecules [20,23,24]. Type IV collagen is expressed in corneas and implicated in Goodpasture and Alport syndromes, which are often accompanied by eye abnormalities, but their involvement in eye disorders is still unknown [22,24-26]. COL4A3 has already been implicated in the pathogenesis of polymorphous corneal dystrophy-3 [27,28], and both genes are reported to be differentially expressed in keratoconus corneas [18,19]. Results from the study published by Stachs et al., favored collagen type IV as a candidate gene in keratoconus pathogenesis [19]. Because a change in the expression levels of collagen type IV alpha-3 and alpha-4 chains were observed in corneas affected by KC, we investigated whether there are alterations in COL4A3 and COL4A4 related to KC patients.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients
###end title 15
###begin p 16
###xml 41 49 <span type="species:ncbi:9606">patients</span>
###xml 126 134 <span type="species:ncbi:9606">patients</span>
###xml 256 264 <span type="species:ncbi:9606">patients</span>
###xml 324 332 <span type="species:ncbi:9606">patients</span>
###xml 584 592 <span type="species:ncbi:9606">patients</span>
###xml 758 766 <span type="species:ncbi:9606">patients</span>
###xml 825 833 <span type="species:ncbi:9606">patients</span>
###xml 1054 1059 <span type="species:ncbi:9606">women</span>
###xml 1065 1068 <span type="species:ncbi:9606">men</span>
###xml 1125 1133 <span type="species:ncbi:9606">patients</span>
###xml 1238 1246 <span type="species:ncbi:9606">patients</span>
###xml 1584 1592 <span type="species:ncbi:9606">patients</span>
The genetic study included 104 unrelated patients with KC and 157 healthy blood donors as a control. After examination of the patients (clinical examination, electronic refractometry, and keratometry) and precise personal anamnesis, an unrelated cohort of patients diagnosed with KC was selected for this study. We excluded patients with other ocular diseases that could influence the interpretation of the results: blepharoconjunctivitis, keratitis, opacifications of the lens, changes of the macula, and cup/disc ratio  (C/D) of the optic nerve of 0.3 or more. One hundred and four patients, 65 males and 39 females, were included in this study after informed consent had been obtained and after determination of the diagnostic and other criteria. All the patients included in the study had no other diagnosed disease. The patients' ages were from 20 to 67 years (mean+/-standard deviation [SD] 39.1+/-8.2 years). For the control population we used peripheral blood taken from 157 blood donors collected at the Blood Transfusion Centre of Slovenia (57 women, 100 men; mean age +/- SD 37.2+/-10.2 years). Blood samples from patients with KC and from healthy Slovenian blood donors were in the form of anticoagulated blood. Blood from KC patients and controls was obtained from the median cubital vein, on the anterior forearm in 3 ml vacuum blood collection tubes with EDTA K3 (Laboratorijska tehnika). Blood was stored in collection tubes at -20 degreesC until the DNA was isolated. The control group was selected on the basis of age, nationality, and gender comparable with the KC patients. There were no blood relations among individuals in the control group or between individuals in the control group and individuals in the KC group, and control individuals had not been diagnosed with KC. The National Medical Ethics Committee of the Republic of Slovenia approved the study.
###end p 16
###begin title 17
DNA extraction and mutational screening
###end title 17
###begin p 18
###xml 615 616 611 612 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1504 1510 1488 1494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 1515 1521 1499 1505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A4</italic>
###xml 1634 1636 1618 1620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 1639 1645 1623 1629 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 1647 1654 1631 1638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 1673 1675 1657 1659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 1678 1684 1662 1668 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A4</italic>
###xml 1686 1693 1670 1677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
Genomic DNA was isolated from peripheral blood lymphocytes by salt precipitation. After the blood samples were thawed, saline-sodium citrate buffer (Merck) was added, mixed on Vibromix (Tehtnica), and the samples centrifuged (12,000 rpm for one minute, centrifuge 5415R; Eppendorf). The top portion of the supernatant was discarded and saline-sodium citrate buffer (Merck) was added, mixed, and again mixture centrifuged under same conditions. Then was supernatant discarded and pellet re-suspended in a solution of sodium dodecyl sulfate detergent (10 % SDS; Sigma-Aldrich) and 5 microl of proteinase K (20 mg/ml H2O; Sigma-Aldrich). The mixture was incubated at 55 degreesC for 1 h (Thermomixer comfort; Eppendorf). After incubation was DNA treated with a phenol/chloroform/isoamyl alcohol solution in ratio 25:24:1 (Sigma-Aldrich).  After centrifugation (12,000 rpm for 1 min, centrifuge 5415R; Eppendorf) was the aqueous layer removed to a new micro centrifuge tube (Costar) and two consecutive DNA ethanol precipitations followed; first one with 100 % and second one with 80 % ethanol (Merck). DNA was re-suspended in 10:1 Tris-EDTA buffer (Sigma-Aldrich) between both precipitations. After the second precipitation the pellets were dried at room temperature followed by addition of 10:1 Tris-EDTA buffer (Sigma-Aldrich). The mixture of DNA and Tris-EDTA buffer (Sigma-Aldrich) was re-suspended with mixing and incubation at 55 degreesC overnight (Thermomixer comfort; Eppendorf). Amplifications of COL4A3 and COL4A4 were performed by PCR. For the PCR reaction we used the primers (Operon) previously described by Heidet et al. [29] (COL4A3; Table 1) and Boye et al. [22] (COL4A4; Table 2).
###end p 18
###begin title 19
###xml 116 122 116 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
Oligonucleotide primers and PCR temperatures used for single-stranded conformational analysis and sequencing of the COL4A3 gene [29].
###end title 19
###begin p 20
In the table, Length represents length of the PCR product in base pairs (bp) and Annealing temp represents the annealing temperature of the primers used for PCR reactions.
###end p 20
###begin title 21
###xml 116 122 116 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A4</italic>
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
Oligonucleotide primers and PCR temperatures used for single-stranded conformational analysis and sequencing of the COL4A4 gene [22].
###end title 21
###begin p 22
In the table, Length represents length of the PCR product in base pairs (bp) and Annealing temp represents the annealing temperature of the primers used for PCR reactions.
###end p 22
###begin p 23
###xml 432 433 432 433 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1214 1216 1196 1198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
###xml 1599 1607 1575 1583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 1612 1620 1588 1596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2</xref>
###xml 155 163 <span type="species:ncbi:9606">patients</span>
Screening for changes in PCR products was performed with single-stranded conformation analysis (SSCA) for each PCR fragment of a given set of samples from patients and healthy blood donors. Large glass plates (35x40 cm) were used to obtain maximum sensitivity. The shorter plate was coated with Repel-Silane (Merck). The longer plate was coated with Bind-Silane (20 ml of g-methacryloxypropyltrimethoxysilane, 5 ml of bi-distilled H2O, 5 ml of 100 % ethanol; Merck), then warmed to 50 degreesC for about 30 min and cooled to room temperature. A 3 ml portion of PCR product was mixed with 10 ml of loading buffer (95% formamide, 5 mM NaOH, 0.1% bromophenol blue, and 0.1% xylene cyanol, Sigma-Aldrich). Samples were heated to 95 degreesC for 2 min and then cooled in ice water. Each PCR product mixed with loading buffer was loaded onto polyacrylamide gels (35x40x0.04 cm). Combs with 96 teeth were used for loading samples and 10% acrylamide gels (Merck) with 2.6% bis-acrylamide (Merck) to analyze multiple exons at once. Gels were run at 4 degreesC in 1x TBE (50mM Tris-borate, pH 8.3, 4 mM ethylenediaminetetraacetic acid; Merck). For DNA visualization, we used the optimized method of Heukeshoven and Dernick [30] with most phases at 55degreesC. Silver staining (Merck) was performed on thin gels (0.4 mm) fixed on the larger glass plate. Samples with different migration shifts were chosen for sequencing, which was done with a BigDye Terminator Ready Reaction Mix (Applied Biosystems). Sequences were purified, dissolved, and analyzed on an ABI PRISM 310 Genetic Analyzer (Applied Biosystems; Figure 1 and Figure 2).
###end p 23
###begin p 24
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 97 103 97 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 353 354 353 354 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 430 431 430 431 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 577 583 577 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 726 732 726 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 880 886 880 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 601 609 <span type="species:ncbi:9606">patients</span>
A: Three different PCR-single stranded conformational analysis patterns on one gel, representing COL4A3 exons 17, 48, and 49. PCR fragments were loaded in succession from shortest to longest PCR fragment at 30-min intervals. Exons 48 and 49 did not show any differences in elution shifts; in exon 17, the different patterns were subsequently sequenced. B: Partial sequence of exon 17 with heterozygous substitution D326Y (976GT). C: Partial sequence of exon 17 with homozygous substitution 326Y (976TT). K1 to K4 marked patterns are patterns of three exons (17, 48, and 49) of COL4A3 from keratoconus patients, multiplied by PCR and analysed with SSCA. C1 to C3 marked patterns are patterns of three exons (17, 48, and 49) of COL4A3 from controls multiplied by PCR and analysed with SSCA. '1/1', '2/2' denote different genotypes at position 976 (1/2 being GT and 2/2 being TT) in COL4A3. GG genotypes, being  '1/1' genotypes, are unmarked. Single stranded DNA (ssDNA) and double stranded DNA (dsDNA) patterns are marked on the side of the SSCA gel.
###end p 24
###begin p 25
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 97 103 97 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A4</italic>
###xml 347 348 347 348 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 504 505 504 505 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 730 736 730 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A4</italic>
A: Three different PCR-single stranded conformational analysis patterns on one gel, representing COL4A4 exons 9, 10, and 42. PCR fragments were loaded in succession from shortest to longest PCR fragment at 30-min intervals. Exons 9 and 10 did not show any differences in elution shifts; in exon 42, different patterns were subsequently sequenced. B: Partial sequence of exon 42, made with reverse primer, showing homozygous substitution 1327M (3797AA). The position marked on reverse sequence is 3797TT. C: Partial sequence of exon 42, made with reverse primer, showing homozygous substitution 1327V (3797GG). The position marked on reverse sequence is 3797CC. '1/1','1/2' and '2/2' denote different genotypes at position 1327 in COL4A4. Single stranded DNA (ssDNA) and double stranded DNA (dsDNA) patterns are marked on the side of the SSCA gel.
###end p 25
###begin title 26
Deviations of the Hardy-Weinberg equilibrium
###end title 26
###begin p 27
###xml 79 80 77 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 195 196 191 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 490 497 486 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 147 155 <span type="species:ncbi:9606">patients</span>
Deviations of the Hardy-Weinberg (H-W) equilibrium were calculated with the chi2 with 1 degree of freedom (DF=1) for each polymorphism found in KC patients and control groups. By the use of a chi2 table, with DF=1, the limits for maintaining a null hypothesis (that the observed data has Hardy-Weinberg proportions) were obtained. If the result equaled or was less than 0.05 (5% limits), we concluded that there was no statistical deviation from the Hardy-Weinberg equilibrium in our data (Table 3).
###end p 27
###begin title 28
###xml 49 57 <span type="species:ncbi:9606">patients</span>
Data about observed polymorphisms in keratoconus patients and controls with calculated deviation from Hardy-Weinberg equilibrium.
###end title 28
###begin p 29
###xml 125 127 125 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r34">34</xref>
 ref ID: identity numbers for observed variants; ref*: polymorphism is not listed in dbSNP, but was reported by Wang et al. [34]. Hardy-Weinberg CHI (p-value): calculated chi values according to our data for cases and controls separately, and deviation between observed and expected numbers. When p-value equals or is less than 0.05 (5%) limit, then there is no statistical deviation from the Hardy-Weinberg equilibrium.
###end p 29
###begin title 30
Associations between allele and genotype frequencies
###end title 30
###begin p 31
###xml 303 304 301 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 705 712 703 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 85 93 <span type="species:ncbi:9606">patients</span>
###xml 617 625 <span type="species:ncbi:9606">patients</span>
The magnitudes and directions of associations between the polymorphisms found and KC patients were determined using Fisher's exact test with a two-sided p value. Fisher's exact test was chosen because it is based on exact probabilities from a specific distribution and is the preferred tool over the chi2 when comparing small data samples and a large sample approximation would be inappropriate. A two-sided p value was calculated to determine the significance of the relationship, and a value of p<0.05 was considered statistically significant. Significant relationships for each allele or genotype group between KC patients and the control group are summarized as odds ratio (OR) and relative risk (RR; Table 4).
###end p 31
###begin title 32
###xml 46 52 46 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 57 63 57 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A4</italic>
###xml 98 106 <span type="species:ncbi:9606">patients</span>
Allele frequencies and their significances in COL4A3 and COL4A4 polymorphisms between keratoconus patients and control population.
###end title 32
###begin p 33
###xml 46 54 <span type="species:ncbi:9606">patients</span>
###xml 299 307 <span type="species:ncbi:9606">patients</span>
Cases: number of alleles found in keratoconus patients, Controls: number of alleles found in healthy blood donor population, n: number of all alleles, p-value: two sided p-value calculated with Fisher's exact test for determining the significance between differences in alleles found in keratoconus patients and controls for each polymorphism, OR: odds ratio, RR: relative risk. OR and RR are shown only for polymorphisms for which allele differences are significant (p-value less than 0.05).
###end p 33
###begin p 34
###xml 535 542 535 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t5">Table 5</xref>
###xml 935 942 935 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t5">Table 5</xref>
###xml 1092 1099 1092 1099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t6">Table 6</xref>
###xml 95 103 <span type="species:ncbi:9606">patients</span>
###xml 1016 1024 <span type="species:ncbi:9606">patients</span>
The significance of genotype frequencies for each polymorphism found in the two-tested groups (patients and controls) was tested in two models, dominant and recessive. A dominant model was constructed on the basis of a presumption that at least one allele would be changed. We therefore combined the number of heterozygous genotypes with the number of homozygous genotypes for each polymorphism genotype and analyzed whether the representation of genotypes was significantly different between cases and controls for each polymorphism (Table 5). A recessive model was constructed on the basis of a presumption that both alleles would be changed. Therefore the number of homozygous genotypes against combined heterozygous and homozygous genotypes for another allele were compared for each polymorphism and whether the representation of genotypes was significantly different between cases and controls for each polymorphism was analyzed (Table 5). An additive model was constructed to test the significances between KC patients and the control group for all genotypes in detected polymorphisms (Table 6). For statistics we used the Fisher's exact test, and when the two-sided value was less than 0.05, the results were summarized as an OR and RR. All statistical analyses were performed using SPSS ver.14 (SPSS Inc.).
###end p 34
###begin title 35
###xml 96 104 <span type="species:ncbi:9606">patients</span>
Genotype representation and associations under dominant and recessive model between keratoconus patients and controls.
###end title 35
###begin p 36
###xml 62 70 <span type="species:ncbi:9606">patients</span>
Significant differences are shown in bold. Cases: keratoconus patients, Controls: healthy blood donors, n: number of individuals, NC- not calculated, Genotype: Genotypes found representing each polymorphism in cases and controls. Fisher's exact test was used for statistics. Differences between genotypes are significant when two-sided p-value (p-value) is less than 0.05. OR: Odds ratio, RR: relative risk. OR and RR are shown only for genotypes with significant differences (p-value less than 0.05). Dominant model column shows Fisher's test results calculated from the sum of the number of individuals with homozygous and heterozygous genotypes compared to the number of individuals with another homozygous genotype for each polymorphism. Recessive model column shows Fisher's test results obtained by comparing the number of individuals with homozygous genotype against the sum of individuals with another homozygous or heterozygous genotype for each polymorphism.
###end p 36
###begin title 37
###xml 82 90 <span type="species:ncbi:9606">patients</span>
Genotype representation and associations under additive model between keratoconus patients and controls.
###end title 37
###begin p 38
###xml 101 108 101 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t5">Table 5</xref>
###xml 126 134 <span type="species:ncbi:9606">patients</span>
Significant differences are shown in bold. Statistics were based on genotype representation shown in Table 5 (104 keratoconus patients and 157 controls). NC- not calculated, Genotype: Genotypes found representing each polymorphism in cases and controls. Fisher's exact test was used for statistics. Genotype comparison: genotypes compared against each other. Differences between genotypes are significant when two-sided p-value (p-value) is less than 0.05. OR: Odds ratio, RR: relative risk. OR and RR are shown only for genotypes with significant differences (p-value less than 0.05).
###end p 38
###begin title 39
SIFT and PolyPhen predictions for polymorphisms causing amino acid substitution
###end title 39
###begin p 40
###xml 697 704 697 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t7">Table 7</xref>
###xml 1339 1346 1339 1346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t7">Table 7</xref>
###xml 721 726 <span type="species:ncbi:9606">Women</span>
###xml 873 878 <span type="species:ncbi:9606">human</span>
The potential impact of polymorphisms causing amino acid substitution was assessed with two analytic tools: SIFT and PolyPhen.  is a sequence homology-based tool that sorts intolerant from tolerant amino acid substitutions and predicts whether an amino acid substitution in a protein will have a phenotypic effect. SIFT is based on the premise that protein evolution is correlated with protein function. Positions important for function should be conserved in the alignment of the protein family, whereas unimportant positions should appear diverse in the alignment. The SIFT tool calculates a score for the amino acid substitution, and a score lower than 0.05 is considered potentially damaging (Table 7).  (Brigham and Women's Hospital, Harvard Medical School) is a tool for predicting the possible impact of an amino acid substitution on the structure and function of a human protein. This prediction is based on straightforward empirical rules, which are applied to the sequence, phylogenetic, and structural information characterizing the substitution. The PolyPhen tool uses Position-Specific Independent Counts software to calculate profile scores obtained from the likelihood of a given amino acid occurring at a position of interest compared to background frequencies (the likelihood of this amino acid occurring at any position; Table 7).
###end p 40
###begin title 41
Prediction of effect of substitution polymorphisms found in KC and healthy population.
###end title 41
###begin p 42
###xml 131 136 <span type="species:ncbi:9606">human</span>
The  (Polymorphism Phenotyping) tool predicts the possible impact of an amino acid substitution on the structure and function of a human protein using straightforward physical and comparative considerations. The  (Sorting Intolerant From Tolerant) tool predicts whether an amino acid substitution will affect the protein function; based on sequence homology and the physical properties of amino acids it calculates the potential impact of the amino acid change (score lower than 0.05 is considered potentially damaging).
###end p 42
###begin title 43
Results
###end title 43
###begin title 44
Mutational analysis
###end title 44
###begin p 45
###xml 36 42 36 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 47 53 47 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A4</italic>
###xml 140 146 140 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 252 258 252 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A4</italic>
###xml 326 333 326 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 335 343 335 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 348 356 348 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2</xref>
###xml 477 484 477 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 95 103 <span type="species:ncbi:9606">patients</span>
Mutational analysis of all exons in COL4A3 and COL4A4 genes did not reveal any mutations in KC patients. We detected eight polymorphisms in COL4A3, six of them amino substitutions (G43R, P141L, E162G, D326Y, H451R, and P574L), and six polymorphisms in COL4A4, three of them amino acid substitutions (P482S, G545A, and M1327V; Table 3, Figure 1 and Figure 2). All of the polymorphisms were also detected in the healthy population and have previously been described as showen in Table 3.
###end p 45
###begin title 46
Hardy-Weinberg equilibrium
###end title 46
###begin p 47
###xml 182 188 182 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 467 474 467 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A4,</italic>
###xml 665 672 665 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 152 160 <span type="species:ncbi:9606">patients</span>
###xml 317 324 <span type="species:ncbi:9606">patient</span>
###xml 609 616 <span type="species:ncbi:9606">patient</span>
When analyzing the H-W equilibrium, we discovered that the frequencies of most of the polymorphisms discovered deviate from expected numbers in both KC patients and controls. In the COL4A3 gene, only three (P141L, D326Y, and G895G) polymorphisms in the control group and two (D326Y and P574L) polymorphisms in the KC patient group had a p value less than the 5% limit, which was the cut-off value for determining no statistical deviation from the H-W equilibrium. In COL4A4, the observed frequencies of three polymorphisms (P428S, M1327V, and V1516V) in the control group and two (G789G and M1327V) in the KC patient group did not deviate from the H-W equilibrium (Table 3).
###end p 47
###begin title 48
Associations between allele and genotype frequencies
###end title 48
###begin p 49
###xml 91 98 91 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 128 134 128 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 176 182 176 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A4</italic>
###xml 325 332 325 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 334 341 334 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t5">Table 5</xref>
###xml 347 354 347 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t6">Table 6</xref>
###xml 423 429 423 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 463 469 463 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A4</italic>
###xml 506 512 506 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A4</italic>
###xml 530 537 530 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 755 762 755 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 81 89 <span type="species:ncbi:9606">patients</span>
###xml 221 229 <span type="species:ncbi:9606">patients</span>
###xml 397 405 <span type="species:ncbi:9606">patients</span>
###xml 630 638 <span type="species:ncbi:9606">patients</span>
###xml 740 747 <span type="species:ncbi:9606">patient</span>
The allele frequency in three polymorphisms was significantly associated with KC patients (Table 4). P141L, D326Y, and G895G in COL4A3 and P482S, M1327V, V1516V, and F1644F in COL4A4 polymorphisms were associated with KC patients, either as genotypes or alleles, with calculated p values less than 0.05 (Fisher's exact test; Table 4, Table 5, and Table 6). Significantly represented alleles in KC patients are 976G (D326Y, COL4A3) with OR= 15.017, 3979G (M1327V, COL4A4) with OR= 2.497, and 4932C (F1644F, COL4A4) with OR= 1.750 (Table 4). When analyzing the representation of genotypes for all the polymorphisms found between KC patients and controls, we discovered that some of the genotypes were significantly represented only in the KC patient group (Table 4). The analysis was performed in relation to the representation of mandatory both (recessive) or at least one allele (dominant) being changed.
###end p 49
###begin p 50
###xml 84 90 84 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 160 166 160 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A4</italic>
###xml 209 216 209 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t5">Table 5</xref>
###xml 334 340 334 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 377 383 377 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A4</italic>
###xml 395 402 395 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t5">Table 5</xref>
###xml 199 207 <span type="species:ncbi:9606">patients</span>
In terms of the dominant model, genotypes 422CC (OR=8.524) and 976GG (OR=30.645) in COL4A3 and 3979GG (OR=12.922), 4548AA (OR=1.993), and 4932CC (OR= 2.890) in COL4A4 are significantly related to KC patients (Table 5). Significantly higher represented genotypes with the recessive model are 976GG (OR=16.545) and 2685CC (OR=2.977) in COL4A3 and 1444TT (OR=2.788) and 4932CC in COL4A4 (OR=1.701; Table 5).
###end p 50
###begin p 51
###xml 147 153 147 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 180 186 180 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A4</italic>
###xml 230 236 230 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 271 277 271 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A4</italic>
###xml 303 310 303 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t5">Table 5</xref>
###xml 395 401 395 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 460 466 460 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A4</italic>
###xml 539 546 539 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t6">Table 6</xref>
###xml 117 125 <span type="species:ncbi:9606">patients</span>
###xml 507 515 <span type="species:ncbi:9606">patients</span>
We also discovered through analysis of both models that some of the genotypes were significantly less frequent in KC patients: 976TT and 2685AA in COL4A3 and 1444CC and 4932 TT in COL4A4 for the dominant model; 422TT and 976TT in COL4A3 and 3979AA, 4548GG, and 4932TT in COL4A4 for the recessive model (Table 5). In the additive model, genotypes 422CC, 422TT, 422CT, 976GG, 976TT, and 2685AA in COL4A3 and 1444CT, 3979AA, 3979GG, 4548AG, 4932CC, and 4932CT in COL4A4 were significantly different between KC patients and the control group (Table 6).
###end p 51
###begin title 52
SIFT and PolyPhen predictions
###end title 52
###begin p 53
###xml 84 90 84 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 159 165 159 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A4</italic>
###xml 253 259 253 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 273 279 273 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A4</italic>
###xml 426 433 426 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t7">Table 7</xref>
PolyPhen analysis predicted that G43R, P141L, D326Y, and P574L polymorphisms in the COL4A3 gene are potentially damaging. All tested missense polymorphisms in COL4A4 are predicted to be benign. SIFT tool analysis gave a score less than 0.05 for G43R in COL4A3 and G545A in COL4A4. Those substitutions are predicted to affect the protein function and would not be tolerated. All other substitutions are predicted as tolerated (Table 7).
###end p 53
###begin title 54
Discussion
###end title 54
###begin p 55
###xml 553 555 553 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 556 558 556 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r31">31</xref>
###xml 736 742 736 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 747 753 747 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A4</italic>
###xml 962 963 962 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 964 965 964 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 966 968 966 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 969 971 969 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 972 974 972 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 975 977 975 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r31">31</xref>
###xml 111 119 <span type="species:ncbi:9606">patients</span>
###xml 366 374 <span type="species:ncbi:9606">patients</span>
###xml 789 797 <span type="species:ncbi:9606">patients</span>
To our knowledge this is the first report describing the genetic screening of two type IV collagen genes in KC patients. Frequent polymorphisms in affected and healthy populations were found, but no mutations in either of the genes that could be related to KC were discovered. Previous data have revealed that the expression of type IV collagen is deregulated in KC patients and that chromosome locations with genes important in the regulation of collagen synthesis (including type IV collagen) are frequently subjected to aneuploidy and translocation [18,31]. Given the identification of changed amounts of collagen and no affirmative data about relations between mutations in already researched collagen genes and KC, we analyzed the COL4A3 and COL4A4 genes, which are deregulated in KC patients, are often subjected to chromosomal aberrations, and could also be responsible for a decrease in collagen types I and III, a feature often detected in the disease [8,9,11,18,19,31].
###end p 55
###begin p 56
###xml 912 914 912 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r32">32</xref>
###xml 1119 1127 <span type="species:ncbi:9606">patients</span>
All of the alterations found in both genes have already been published in other studies. When analyzing whether polymorphisms found were in H-W equilibrium, we discovered that most of them were not. It is difficult to speculate the main reason for this, but some of the probable causes of population differences shown in the study are selection, small population size, population stratification, and genetic drift. It is not rare to find that polymorphisms are in H-W disequilibrium because of the above-mentioned reasons. The control group was selected as described in the Methods section. Considering the small number of some of the alleles found, it is easy to predict that a larger sample size of controls and inclusion of different nationalities and races could help to meet the criteria for H-W equilibrium, but the allele frequencies described in our study are comparable to ones found by Slajpah et al. [32]. Even though obvious violations to the H-W equilibrium were detected, genotypes and allele representations for some polymorphisms statistically differ between groups and are much more frequent in the KC patients than in the healthy population, which should be taken into consideration when assessing differences between genotypes and phenotypes for a chosen population.
###end p 56
###begin p 57
###xml 188 194 188 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 392 398 392 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A4</italic>
For predicting the effect of substitutions found, we used two different tools, PolyPhen and SIFT, which predict the possible impact on the structure and function of protein substitutions. COL4A3 G43R, P141L, D326Y, and P574L polymorphisms were predicted to have an effect when analyzed with PolyPhen, but SIFT predicted that only G43R would be damaging. Out of all the substitutions found in COL4A4, only G545A was predicted by SIFT to be damaging. Discrepancies between predictions using different tools are expected because the matrices and nature of assessing the damaging effects are based differently. PolyPhen predicts the functional effect of substitutions by determining the level of sequence conservation between homologous genes over evolutionary time, the properties of the exchanged residues, and the proximity of the substitution to predicted putative protein domains and structural features within the protein. SIFT predicts the functional importance of an amino acid substitution based on the alignment of highly similar protein sequences. Predictions rely on whether or not an amino acid at the position of our interest is conserved in the protein family, which can be indicative of its importance to the normal function or structure of the expressed protein. Not all substitutions predicted to affect protein function are involved in disease development and/or progression, especially in the complex diseases, such as KC. Still in the absence of functional data, it is advantageous to use predictive tools to identify substitutions that would more likely affect wild-type protein function; nevertheless differences in results using prediction tools and statistical evaluation of allele/genotype distribution between groups are to be expected.
###end p 57
###begin p 58
###xml 121 123 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 128 134 128 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 147 149 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 150 152 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
###xml 173 179 173 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A4</italic>
###xml 544 550 544 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A4</italic>
###xml 1019 1025 1019 1025 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 1060 1066 1060 1066 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A4</italic>
###xml 1197 1204 1197 1204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t7">Table 7</xref>
###xml 209 216 <span type="species:ncbi:9606">patient</span>
###xml 517 525 <span type="species:ncbi:9606">patients</span>
###xml 780 788 <span type="species:ncbi:9606">patients</span>
The allele distributions of three polymorphisms already described in previous studies related to Alport syndrome (D326Y [29] in COL4A3 and M1327V [22,33] and F1644F [33] in COL4A4) were significant for the KC patient cohort. We cannot speculate that these polymorphisms in any way alter the collagen assembly or promote KC disease, although SIFT and PolyPhen predict D326Y to be damaging and the substitution could have an effect on the structure and function of the protein. The other two alleles significant for KC patients were found in the COL4A4 gene, resulting in one missense and one silent alteration (3979G, M1327V and 4932C, F1644F), although substitution is predicted to be benign and tolerated. When comparing genotypes, we discovered specific genotypes related to KC patients even though the allele distribution was not significantly different. Under different models (dominant, recessive, and additive), we found a significant representation of the following genotypes: 422CC, 422TT, 422CT, and 2685CC in COL4A3 and 1444TT, 4548AA, and 4548AG in COL4A4. The prediction tools used showed the possibility that some of the substitution resulting from these genotypes could be damaging (Table 7). In order to conclude whether genotype representations are specific for our population or are in fact disease specific, different populations should be examined and data compared.
###end p 58
###begin p 59
###xml 89 95 89 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 100 106 100 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A4</italic>
###xml 398 404 398 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 409 415 409 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A4</italic>
###xml 362 370 <span type="species:ncbi:9606">patients</span>
In view of the lack of mutations, we could speculate that mutations in collagen type IV (COL4A3 and COL4A4 genes) are not involved in KC disease and that other genes and factors are involved in the pathogenesis of this disorder, but functional assay would be required to clarify this speculation. This study established that significant relationships between KC patients and different genotypes in COL4A3 and COL4A4 exist, so the significance of the genotypes should be established by further analysis that would involve different populations. There is a possibility that some of the polymorphisms could be related to KC, a feature that could be used in helping the determination of the molecular genetics of the disease.
###end p 59
###begin title 60
Acknowledgments
###end title 60
###begin p 61
The Slovenian Research Agency (ARRS; Program P3-054) supported this work.
###end p 61
###begin title 62
References
###end title 62
###begin article-title 63
Keratoconus.
###end article-title 63
###begin article-title 64
VSX1: a gene for posterior polymorphous dystrophy and keratoconus.
###end article-title 64
###begin article-title 65
Discordance for keratoconus in two pairs of monozygotic twins.
###end article-title 65
###begin article-title 66
Detection of specific collagen types in normal and keratoconus corneas.
###end article-title 66
###begin article-title 67
Genetic epidemiological study of keratoconus: evidence for major gene determination.
###end article-title 67
###begin article-title 68
A 48-year clinical and epidemiologic study of keratoconus.
###end article-title 68
###begin article-title 69
###xml 75 83 <span type="species:ncbi:9606">patients</span>
Levels of collagen degradation products (telopeptides) in the tear film of patients with keratoconus.
###end article-title 69
###begin article-title 70
Keratoconus: I. Biochemical studies.
###end article-title 70
###begin article-title 71
Abnormalities of the extracellular matrix in keratoconus corneas.
###end article-title 71
###begin article-title 72
The structure and transparency of the cornea.
###end article-title 72
###begin article-title 73
Changes in collagen orientation and distribution in keratoconus corneas.
###end article-title 73
###begin article-title 74
###xml 50 54 <span type="species:ncbi:10090">mice</span>
Targeted disruption of Col8a1 and Col8a2 genes in mice leads to anterior segment abnormalities in the eye.
###end article-title 74
###begin article-title 75
Keratoconus is not associated with mutations in COL8A1 and COL8A2.
###end article-title 75
###begin article-title 76
Missense mutations in COL8A2, the gene encoding the alpha2 chain of type VIII collagen, cause two forms of corneal endothelial dystrophy.
###end article-title 76
###begin article-title 77
Inheritance of a novel COL8A2 mutation defines a distinct early-onset subtype of fuchs corneal dystrophy.
###end article-title 77
###begin article-title 78
###xml 102 107 <span type="species:ncbi:9606">human</span>
Differential expression of collagen types XVIII/endostatin and XV in normal, keratoconus, and scarred human corneas.
###end article-title 78
###begin article-title 79
###xml 68 73 <span type="species:ncbi:9606">human</span>
Altered expression of type XIII collagen in keratoconus and scarred human cornea: Increased expression in scarred cornea is associated with myofibroblast transformation.
###end article-title 79
###begin article-title 80
Gene expression in keratoconus. Initial results using DNA microarrays.
###end article-title 80
###begin article-title 81
The extracellular matrix structure in keratoconus.
###end article-title 81
###begin article-title 82
Colocalization of the genes for the alpha-3(IV) and alpha-4(IV) chains of type IV collagen to chromosome 2 bands q35-q37.
###end article-title 82
###begin article-title 83
###xml 44 49 <span type="species:ncbi:9606">human</span>
Two genes, COL4A3 and COL4A4 coding for the human alpha-3(IV) and alpha-4(IV) collagen chains are arranged head-to-head on chromosome 2q36.
###end article-title 83
###begin article-title 84
Determination of the genomic structure of the COL4A4 gene and of novel mutations causing autosomal recessive Alport syndrome.
###end article-title 84
###begin article-title 85
###xml 25 30 <span type="species:ncbi:9606">human</span>
Molecular cloning of the human Goodpasture antigen demonstrates it to be the alpha-3 chain of type IV collagen.
###end article-title 85
###begin article-title 86
###xml 60 65 <span type="species:ncbi:9606">human</span>
Type IV collagen: structure, gene organization, and role in human diseases. Molecular basis of Goodpasture and Alport syndromes and diffuse leiomyomatosis.
###end article-title 86
###begin article-title 87
Identification of mutations in the alpha-3(IV) and alpha-4(IV) collagen genes in autosomal recessive Alport syndrome.
###end article-title 87
###begin article-title 88
The clinical spectrum of type IV collagen mutations.
###end article-title 88
###begin article-title 89
###xml 42 47 <span type="species:ncbi:9606">human</span>
Microarray analysis of gene expression in human donor corneas.
###end article-title 89
###begin article-title 90
Mutations in TCF8 cause posterior polymorphous corneal dystrophy and ectopic expression of COL4A3 by corneal endothelial cells.
###end article-title 90
###begin article-title 91
###xml 17 22 <span type="species:ncbi:9606">human</span>
Structure of the human type IV collagen gene COL4A3 and mutations in autosomal Alport syndrome.
###end article-title 91
###begin article-title 92
Native horizontal ultrathin polyacrylamide gel electrophoresis of proteins under basic and acidic conditions.
###end article-title 92
###begin article-title 93
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human cornea has a high incidence of acquired chromosome abnormalities.
###end article-title 93
###begin article-title 94
Sixteen novel mutations indentified in COL4A3, COL4A4 and COL4A5 genes in Slovenian families with Alport syndrome and benign familial hematuria.
###end article-title 94
###begin article-title 95
COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome.
###end article-title 95
###begin article-title 96
COL4A3 mutations and their clinical consequences in thin basement membrane nephropathy (TBMN)
###end article-title 96

